These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 3402898)
1. 5-Hydroxytryptamine stimulates two distinct adenylate cyclase activities in rat brain: high-affinity activation is related to a 5-HT1 subtype different from 5-HT1A, 5-HT1B, and 5-HT1C. Fayolle C; Fillion MP; Barone P; Oudar P; Rousselle JC; Fillion G Fundam Clin Pharmacol; 1988; 2(3):195-214. PubMed ID: 3402898 [TBL] [Abstract][Full Text] [Related]
2. Pharmacological differentiation and characterization of 5-HT1A, 5-HT1B, and 5-HT1C binding sites in rat frontal cortex. Peroutka SJ J Neurochem; 1986 Aug; 47(2):529-40. PubMed ID: 2942638 [TBL] [Abstract][Full Text] [Related]
3. 5-Hydroxytryptamine receptor agonists influence calcium-stimulated adenylate cyclase activity in the cerebral cortex and hippocampus of the rat. Mørk A; Geisler A Eur J Pharmacol; 1990 Jan; 175(3):237-44. PubMed ID: 2138981 [TBL] [Abstract][Full Text] [Related]
4. Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (-)[125I]iodocyanopindolol, [3H]mesulergine and [3H]ketanserin. Hoyer D; Engel G; Kalkman HO Eur J Pharmacol; 1985 Nov; 118(1-2):13-23. PubMed ID: 2935410 [TBL] [Abstract][Full Text] [Related]
5. Identification of a 5-HT1 recognition site in human brain membranes different from 5-HT1A, 5-HT1B and 5-HT1C sites. Hoyer D; Waeber C; Pazos A; Probst A; Palacios JM Neurosci Lett; 1988 Mar; 85(3):357-62. PubMed ID: 2966310 [TBL] [Abstract][Full Text] [Related]
6. 5-HT1B receptors are negatively coupled with adenylate cyclase in rat substantia nigra. Bouhelal R; Smounya L; Bockaert J Eur J Pharmacol; 1988 Jul; 151(2):189-96. PubMed ID: 2971554 [TBL] [Abstract][Full Text] [Related]
7. Activity of serotonin (5-HT) receptor agonists, partial agonists and antagonists at cloned human 5-HT1A receptors that are negatively coupled to adenylate cyclase in permanently transfected HeLa cells. Pauwels PJ; Van Gompel P; Leysen JE Biochem Pharmacol; 1993 Jan; 45(2):375-83. PubMed ID: 8382063 [TBL] [Abstract][Full Text] [Related]
8. 5-HT1A-receptors mediate stimulation of adenylate cyclase in rat hippocampus. Markstein R; Hoyer D; Engel G Naunyn Schmiedebergs Arch Pharmacol; 1986 Aug; 333(4):335-41. PubMed ID: 2945992 [TBL] [Abstract][Full Text] [Related]
9. A nonclassical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system. Dumuis A; Bouhelal R; Sebben M; Cory R; Bockaert J Mol Pharmacol; 1988 Dec; 34(6):880-7. PubMed ID: 2849052 [TBL] [Abstract][Full Text] [Related]
10. Characterization of a novel 3H-5-hydroxytryptamine binding site subtype in bovine brain membranes. Heuring RE; Peroutka SJ J Neurosci; 1987 Mar; 7(3):894-903. PubMed ID: 2951504 [TBL] [Abstract][Full Text] [Related]
11. [3H]1-[2-(4-aminophenyl)ethyl]-4-(3-trifluoromethylphenyl)piperazine: a selective radioligand for 5-HT1A receptors in rat brain. Ransom RW; Asarch KB; Shih JC J Neurochem; 1986 Jan; 46(1):68-75. PubMed ID: 2933490 [TBL] [Abstract][Full Text] [Related]
12. Centrally acting hypotensive agents with affinity for 5-HT1A binding sites inhibit forskolin-stimulated adenylate cyclase activity in calf hippocampus. Schoeffter P; Hoyer D Br J Pharmacol; 1988 Nov; 95(3):975-85. PubMed ID: 3207999 [TBL] [Abstract][Full Text] [Related]
13. Postnatal development of 5-HT1 receptors: [3H]5-HT binding sites and 5-HT induced adenylate cyclase activations in rat brain cortex. Zifa E; Hernandez J; Fayolle C; Fillion G Brain Res Dev Brain Res; 1988 Nov; 44(1):133-40. PubMed ID: 3233729 [TBL] [Abstract][Full Text] [Related]
14. Differential selectivities of RU 24969 and 8-OH-DPAT for the purported 5-HT1A and 5-HT1B binding sites. Correlation between 5-HT1A affinity and hypotensive activity. Doods HN; Kalkman HO; De Jonge A; Thoolen MJ; Wilffert B; Timmermans PB; Van Zwieten PA Eur J Pharmacol; 1985 Jun; 112(3):363-70. PubMed ID: 3160596 [TBL] [Abstract][Full Text] [Related]
15. Stimulation and inhibition of adenylyl cyclase by distinct 5-hydroxytryptamine receptors. De Vivo M; Maayani S Biochem Pharmacol; 1990 Oct; 40(7):1551-8. PubMed ID: 2222510 [TBL] [Abstract][Full Text] [Related]
16. Identification of multiple binding sites for [3H]5-hydroxytryptamine in the rat CNS. Blurton PA; Wood MD J Neurochem; 1986 May; 46(5):1392-8. PubMed ID: 3958711 [TBL] [Abstract][Full Text] [Related]
17. Interaction of arylpiperazines with 5-HT1A, 5-HT1B, 5-HT1C and 5-HT1D receptors: do discriminatory 5-HT1B receptor ligands exist? Schoeffter P; Hoyer D Naunyn Schmiedebergs Arch Pharmacol; 1989 Jun; 339(6):675-83. PubMed ID: 2770889 [TBL] [Abstract][Full Text] [Related]
18. Biochemical evidence for the 5-HT agonist properties of PAT (8-hydroxy-2-(di-n-propylamino)tetralin) in the rat brain. Hamon M; Bourgoin S; Gozlan H; Hall MD; Goetz C; Artaud F; Horn AS Eur J Pharmacol; 1984 May; 100(3-4):263-76. PubMed ID: 6203761 [TBL] [Abstract][Full Text] [Related]
19. Pharmacological characterization of two 5-hydroxytryptamine receptors coupled to adenylate cyclase in guinea pig hippocampal membranes. Shenker A; Maayani S; Weinstein H; Green JP Mol Pharmacol; 1987 Apr; 31(4):357-67. PubMed ID: 2952874 [TBL] [Abstract][Full Text] [Related]
20. Pharmacology of 5-hydroxytryptamine-1A receptors which inhibit cAMP production in hippocampal and cortical neurons in primary culture. Dumuis A; Sebben M; Bockaert J Mol Pharmacol; 1988 Feb; 33(2):178-86. PubMed ID: 2828913 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]